Summit Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
VCM
VPM
Summit Financial's BSX Position: Q1 2026 in Review
Summit Financial reduced its Boston Scientific (BSX) stake by 30% in Q1 2026, selling an estimated $746K and leaving 21,442 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #680.
Summit Financial first reported a position in BSX in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.51M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Summit Financial held 21,442 shares of Boston Scientific worth $1.35M as of Q1 2026.
- Summit Financial sold 9,322 Boston Scientific shares in Q1 2026, an estimated $746K.
- Boston Scientific made up 0.02% of Summit Financial's portfolio in Q1 2026, its #680 holding.
- Summit Financial first reported a position in Boston Scientific in Q3 2021 and has held it in 19 quarters since.
- Summit Financial's Boston Scientific position peaked at $3.51M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.